Maravai LifeSciences/$MRVI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Maravai LifeSciences
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Ticker
$MRVI
Sector
Primary listing
Employees
416
Headquarters
Website
MRVI Metrics
BasicAdvanced
$732m
-
-$0.72
0.62
-
Price and volume
Market cap
$732m
Beta
0.62
52-week high
$5.30
52-week low
$1.99
Average daily volume
3m
Financial strength
Current ratio
5.906
Quick ratio
4.677
Long term debt to equity
81.17
Total debt to equity
97.853
Interest coverage (TTM)
-3.40%
Profitability
EBITDA (TTM)
-38.025
Gross margin (TTM)
30.12%
Net profit margin (TTM)
-51.07%
Operating margin (TTM)
-43.07%
Effective tax rate (TTM)
2.40%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
-6.59%
Return on equity (TTM)
-40.98%
Valuation
Price to revenue (TTM)
3.516
Price to book
3.46
Price to tangible book (TTM)
-10.51
Price to free cash flow (TTM)
-13.683
Free cash flow yield (TTM)
-7.31%
Free cash flow per share (TTM)
-0.363
Growth
Revenue change (TTM)
-15.35%
Earnings per share change (TTM)
-37.70%
3-year revenue growth (CAGR)
-34.17%
3-year earnings per share growth (CAGR)
-14.79%
What the Analysts think about MRVI
Analyst ratings (Buy, Hold, Sell) for Maravai LifeSciences stock.
MRVI Financial Performance
Revenues and expenses
MRVI Earnings Performance
Company profitability
MRVI News
AllArticlesVideos
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
Business Wire·4 hours ago
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
Business Wire·2 weeks ago
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs